Kristin McLarty

Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts

Kristin McLarty, Bart Cornelissen, Deborah A. Scollard et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2008 · 126 citations

Medicine, Oncology, Pharmacology +14

Trastuzumab-Resistant Breast Cancer Cells Remain Sensitive to the Auger Electron–Emitting Radiotherapeutic Agent ¹¹¹In-NLS-Trastuzumab and Are Radiosensitized by Methotrexate

Danny L. Costantini, Katherine Bateman, Kristin McLarty et al. · Journal of Nuclear Medicine · 2008 · 87 citations · Full text

Medicine, Oncology, Pharmacology +14

Micro-SPECT/CT with ¹¹¹In-DTPA-Pertuzumab Sensitively Detects Trastuzumab-Mediated <i>HER2</i> Downregulation and Tumor Response in Athymic Mice Bearing MDA-MB-361 Human Breast Cancer Xenografts

Kristin McLarty, Bart Cornelissen, Zhongli Cai et al. · Journal of Nuclear Medicine · 2009 · 78 citations · Full text

Medicine, Oncology, Pharmacology +17

Antitumor Effects and Normal-Tissue Toxicity of ¹¹¹In-Nuclear Localization Sequence-Trastuzumab in Athymic Mice Bearing <i>HER</i>-Positive Human Breast Cancer Xenografts

Danny L. Costantini, Kristin McLarty, Helen Lee et al. · Journal of Nuclear Medicine · 2010 · 76 citations · Full text

Medicine, Oncology, Pharmacokinetics +17

Cellular penetration and nuclear importation properties of 111In-labeled and 123I-labeled HIV-1 tat peptide immunoconjugates in BT-474 human breast cancer cells

Bart Cornelissen, Meiduo Hu, Kristin McLarty et al. · Nuclear Medicine and Biology · 2007 · 45 citations

Pharmacy, Molecular Pharmaceutics, Oncology +16